These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 15491807)

  • 21. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP; Chaubal MV; Shorr R
    Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uniform chitosan microspheres for potential application to colon-specific drug delivery.
    Choy YB; Cheng F; Choi H; Kim KK
    Macromol Biosci; 2008 Dec; 8(12):1173-81. PubMed ID: 18702170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nanoscale drug carriers for traditional Chinese medicine research and development].
    Yi CX; Yu JN; Xu XM
    Zhongguo Zhong Yao Za Zhi; 2008 Aug; 33(16):1936-40. PubMed ID: 19086622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential applications of chitosan in veterinary medicine.
    Senel S; McClure SJ
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1467-80. PubMed ID: 15191793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral gene delivery: design of polymeric carrier systems shielding toward intestinal enzymatic attack.
    Martien R; Loretz B; Schnürch AB
    Biopolymers; 2006 Nov; 83(4):327-36. PubMed ID: 16609969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicochemical, pharmaceutical and biological approaches toward designing optimized and efficient hydrophobically modified chitosan-based polymeric micelles as a nanocarrier system for targeted delivery of anticancer drugs.
    Mahmoudzadeh M; Fassihi A; Emami J; Davies NM; Dorkoosh F
    J Drug Target; 2013 Sep; 21(8):693-709. PubMed ID: 23915108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel polymer micelles prepared from chitosan grafted hydrophobic palmitoyl groups for drug delivery.
    Jiang GB; Quan D; Liao K; Wang H
    Mol Pharm; 2006; 3(2):152-60. PubMed ID: 16579644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fabrication of nanoparticles within polymeric pores for controlled release of drug.
    Asif M; Arayne MS; Sultana N; Hussain F
    Pak J Pharm Sci; 2006 Jan; 19(1):73-84. PubMed ID: 16632458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hybrid polymeric hydrogels for ocular drug delivery: nanoparticulate systems from copolymers of acrylic acid-functionalized chitosan and N-isopropylacrylamide or 2-hydroxyethyl methacrylate.
    Barbu E; Verestiuc L; Iancu M; Jatariu A; Lungu A; Tsibouklis J
    Nanotechnology; 2009 Jun; 20(22):225108. PubMed ID: 19433871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential of chitosan in ocular drug delivery.
    Alonso MJ; Sánchez A
    J Pharm Pharmacol; 2003 Nov; 55(11):1451-63. PubMed ID: 14713355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Camptothecin-incorporating N-phthaloylchitosan-g-mPEG self-assembly micellar system: effect of degree of deacetylation.
    Opanasopit P; Ngawhirunpat T; Rojanarata T; Choochottiros C; Chirachanchai S
    Colloids Surf B Biointerfaces; 2007 Oct; 60(1):117-24. PubMed ID: 17644325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biodegradation, biodistribution and toxicity of chitosan.
    Kean T; Thanou M
    Adv Drug Deliv Rev; 2010 Jan; 62(1):3-11. PubMed ID: 19800377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
    Wiradharma N; Tong YW; Yang YY
    Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Solubilizing and sustained-releasing abilities and safety preliminary evaluation for paclitaxel based on N-octyl-O, N-carboxymethyl chitosan polymeric micelles].
    Huo MR; Zhang Y; Zhou JP; Lü L; Liu H; Liu FJ
    Yao Xue Xue Bao; 2008 Aug; 43(8):855-61. PubMed ID: 18956780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microencapsulated chitosan nanoparticles for lung protein delivery.
    Grenha A; Seijo B; Remuñán-López C
    Eur J Pharm Sci; 2005; 25(4-5):427-37. PubMed ID: 15893461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review: doxorubicin delivery systems based on chitosan for cancer therapy.
    Tan ML; Choong PF; Dass CR
    J Pharm Pharmacol; 2009 Feb; 61(2):131-42. PubMed ID: 19178759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stable drug encapsulation in micelles and microemulsions.
    Narang AS; Delmarre D; Gao D
    Int J Pharm; 2007 Dec; 345(1-2):9-25. PubMed ID: 17945446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and evaluation of a chitosan salt-poloxamer 407 based matrix for buccal drug delivery.
    Cafaggi S; Leardi R; Parodi B; Caviglioli G; Russo E; Bignardi G
    J Control Release; 2005 Jan; 102(1):159-69. PubMed ID: 15653142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Past and future evolution in colloidal drug delivery systems.
    Boyd BJ
    Expert Opin Drug Deliv; 2008 Jan; 5(1):69-85. PubMed ID: 18095929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.